Display options
Share it on

Evid Based Complement Alternat Med. 2017;2017:4031950. doi: 10.1155/2017/4031950. Epub 2017 Oct 11.

The Effects of Aqueous Extract from .

Evidence-based complementary and alternative medicine : eCAM

Rayile Aisa, Zhaoxia Yu, Xiangyang Zhang, Dilinuer Maimaitiyiming, Lipeng Huang, Ayshamgul Hasim, Tao Jiang, Mingjun Duan

Affiliations

  1. Cardiac Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China.
  2. Department of Internal Medicine, Kuqa County Hospital of Traditional Uyghur Medicine, Kuqa 842000, China.
  3. Department of Pathology, Xinjiang Medical University, Urumqi 830011, China.
  4. Institute of Clinical Medicine Research, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China.

PMID: 29234388 PMCID: PMC5660807 DOI: 10.1155/2017/4031950

Abstract

AIMS: The aim of this study was to investigate the effects of the aqueous extract of

METHODS: 2K1C rat models were set up by clipping the left renal artery. Sham-operated rats underwent the same surgical procedure except for renal arterial clipping. 2K1C hypertensive rats were orally given NCBAE at doses of 210, 420, and 630 mg·kg

RESULTS: Treatment with NCBAE resulted in a decrease of SBP, LVPWd, LVPWs, IVSd, IVSs, LVW/BW ratio, and cardiomyocyte CSA, an increase of LVEF, and inhibition of 2K1C-induced reduction in serum NO and elevation of LDH compared with 2K1C group. NCBAE intervention also showed a significant increase of Bcl-2 expression and reduction of cleaved caspase-3 level dose-dependently in left ventricular tissue.

CONCLUSION: Our data demonstrate that NCBAE has an antihypertensive property and protective effect on 2K1C-induced cardiac hypertrophy especially at the dose of 630 mg·kg

References

  1. Cardiol Clin. 2001 Feb;19(1):13-29 - PubMed
  2. Heart. 2003 Nov;89(11):1303-7 - PubMed
  3. J Ethnopharmacol. 2003 Jun;86(2-3):181-5 - PubMed
  4. J Mol Cell Cardiol. 2008 Nov;45(5):625-32 - PubMed
  5. Hypertension. 2003 Feb;41(2):249-54 - PubMed
  6. Curr Hypertens Rep. 2010 Aug;12(4):267-75 - PubMed
  7. Evid Based Complement Alternat Med. 2013;2013:687958 - PubMed
  8. Circulation. 2010 Feb 2;121(4):519-28 - PubMed
  9. J Clin Invest. 1996 Jun 15;97(12):2891-7 - PubMed
  10. J Ethnopharmacol. 2014 May 14;153(3):635-40 - PubMed
  11. Cardiovasc Pathol. 2016 Mar-Apr;25(2):116-9 - PubMed
  12. Biochem Biophys Res Commun. 2015 Aug 7;463(4):1012-20 - PubMed
  13. Hypertension. 2001 Dec 1;38(6):1406-12 - PubMed
  14. Eur J Pharmacol. 2014 Apr 5;728:67-76 - PubMed
  15. J Mol Cell Cardiol. 2014 Feb;67:103-11 - PubMed
  16. Prog Neurobiol. 2005 Jun;76(2):126-52 - PubMed
  17. J Cardiovasc Pharmacol. 2014 Aug;64(2):127-33 - PubMed
  18. Genes Dev. 2001 Nov 15;15(22):2922-33 - PubMed
  19. Vascul Pharmacol. 2015 Oct;73:45-56 - PubMed
  20. Phytomedicine. 2011 Sep 15;18(12 ):1024-30 - PubMed
  21. Curr Hypertens Rep. 2004 Oct;6(5):346-51 - PubMed
  22. Br J Pharmacol. 2006 Jan;147 Suppl 1:S193-201 - PubMed
  23. Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2705-13 - PubMed
  24. Hypertension. 2004 Sep;44(3):248-52 - PubMed
  25. Nitric Oxide. 2012 Feb 15;26(2):118-25 - PubMed
  26. Free Radic Biol Med. 2013 Dec;65:47-56 - PubMed
  27. J Huazhong Univ Sci Technolog Med Sci. 2013 Dec;33(6):822-6 - PubMed
  28. J Ethnopharmacol. 2007 Apr 20;111(1):50-5 - PubMed
  29. Zhong Yao Cai. 2007 Jan;30(1):38-41 - PubMed
  30. Adv Med Sci. 2014 Sep;59(2):190-5 - PubMed
  31. Cardiovasc Drugs Ther. 2004 Sep;18(5):353-62 - PubMed
  32. Exp Mol Pathol. 2013 Feb;94(1):1-9 - PubMed
  33. Chin J Nat Med. 2016 May;14 (5):343-53 - PubMed
  34. Curr Opin Cell Biol. 2009 Dec;21(6):871-7 - PubMed
  35. Biochem Biophys Res Commun. 2009 Nov 6;389(1):145-9 - PubMed
  36. Fitoterapia. 2015 Jan;100:195-200 - PubMed
  37. Science. 1998 Aug 28;281(5381):1322-6 - PubMed

Publication Types